ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
$14.89
0.00%
(0.00) 1D
$14.89
0.00% (0.00)
bedtimeAfter hours
Closed: Aug 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALPMY...
Open
$14.89
High
$14.98
Low
$14.83
Mkt. cap
4.26T
Avg. vol.
179.34K
Volume
0.00
52-wk high
$17.35
52-wk low
$10.03
Beta
0.14
Shares outstanding
1.81B
No. of employees
14K
Open
$14.89
High
$14.98
Low
$14.83
Mkt. cap
4.26T
Avg. vol.
179.34K
Volume
0.00
52-wk high
$17.35
52-wk low
$10.03
Beta
0.14
Shares outstanding
1.81B
No. of employees
14K
News stories
From web sources and news partners
The Business Journals
·
2 days ago
Astellas CEO wants more from Cambridge R&D as company faces patent cliff
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com
AI content may include mistakes. Learn more